Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LOMA
2276
Loma Negra
LOMA
$1.1B
| $1.65M | ﹤0.01% |
+387,762
| New | +$1.58M |
|
2277
FB Financial Corp
FBK
$3.09B
| $1.65M | ﹤0.01% |
66,600
-42,700
| -39% | -$951K |
|
2278
iShares Russell 1000 ETF
IWB
$50.4B
| $1.65M | ﹤0.01% |
9,600
-1,100
| -10% | -$178K |
|
2279
Jakks Pacific
JAKK
$294M
| $1.65M | ﹤0.01% |
200,931
-16,774
| -8% | -$110K |
|
2280
KKR & Co
KKR
$102B
| $1.65M | ﹤0.01% |
+53,350
| New | +$1.43M |
|
|
SCX
2281
DELISTED
The L.S. Starrett Company
SCX
| $1.65M | ﹤0.01% |
485,915
+14,593
| +3% | +$49.7K |
|
2282
Boise Cascade
BCC
$2.9B
| $1.64M | ﹤0.01% |
43,700
-83,600
| -66% | -$2.62M |
|
2283
International Bancshares
IBOC
$4.56B
| $1.64M | ﹤0.01% |
51,337
-187,900
| -79% | -$5.4M |
|
2284
Qfin Holdings
QFIN
$1.49B
| $1.64M | ﹤0.01% |
152,900
+110,704
| +262% | +$1.01M |
|
2285
First Trust Dow Jones Internet Index Fund ETF
FDN
$5.38B
| $1.64M | ﹤0.01% |
9,600
+6,000
| +167% | +$916K |
|
|
STZ.B
2286
DELISTED
CONSTELLATION BRANDS, INC. CLASS B
STZ.B
| $1.64M | ﹤0.01% |
9,700
| – | – |
|
2287
Dorian LPG
LPG
$2.03B
| $1.64M | ﹤0.01% |
211,222
-251,298
| -54% | -$2.08M |
|
|
RNTX
2288
Rein Therapeutics
RNTX
$68.9M
| $1.63M | ﹤0.01% |
69,194
+45,335
| +190% | +$739K |
|
2289
Green Brick Partners
GRBK
$3.03B
| $1.63M | ﹤0.01% |
137,735
+60,000
| +77% | +$575K |
|
2290
KT
KT
$9.11B
| $1.63M | ﹤0.01% |
167,500
-93,700
| -36% | -$893K |
|
|
ATYR
2291
aTyr Pharma
ATYR
$54.8M
| $1.62M | ﹤0.01% |
365,830
+156,830
| +75% | +$569K |
|
|
BBQ
2292
DELISTED
BBQ Holdings, Inc. Common Stock
BBQ
| $1.62M | ﹤0.01% |
492,741
+4,500
| +0.9% | +$12.2K |
|
2293
Fortress Biotech
FBIO
$97.3M
| $1.62M | ﹤0.01% |
40,267
+6,967
| +21% | +$259K |
|
|
MBCN
2294
DELISTED
Middlefield Banc Corp
MBCN
| $1.62M | ﹤0.01% |
77,940
-17,872
| -19% | -$331K |
|
|
WRI
2295
DELISTED
Weingarten Realty Investors
WRI
| $1.62M | ﹤0.01% |
85,400
-910,919
| -91% | -$15.9M |
|
2296
Castle Biosciences
CSTL
$905M
| $1.61M | ﹤0.01% |
42,836
+9,636
| +29% | +$329K |
|
2297
First United
FUNC
$293M
| $1.61M | ﹤0.01% |
120,991
+7,490
| +7% | +$106K |
|
2298
ProShares UltraPro Short QQQ
SQQQ
$1.68B
| $1.61M | ﹤0.01% |
+342
| New | +$2.41M |
|
2299
Century Casinos
CNTY
$36M
| $1.61M | ﹤0.01% |
388,049
-483,117
| -55% | -$2.03M |
|
2300
Corbus Pharmaceuticals
CRBP
$195M
| $1.61M | ﹤0.01% |
+6,387
| New | +$1.29M |
|
Similar funds
Jim Simons's Q2 2020 Portfolio in Review
As of Q2 2020, Jim Simons held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,366 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Jim Simons opened a new position in Uber worth $187M.
- Jim Simons's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Jim Simons added most to Zoom in Q2 2020, an estimated $806M increase.
- Jim Simons's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Jim Simons fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Jim Simons's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Jim Simons opened 584 new positions and closed 596 in Q2 2020.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.